Large-scale testing (Phase 3)Study completedNCT01555125
What this trial is testing
First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks
Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 177